Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Revenue (2022 - 2025)

Historic Revenue for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Q3 2025 value amounting to $99.2 million.

  • Arcutis Biotherapeutics' Revenue rose 12169.37% to $99.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $317.9 million, marking a year-over-year increase of 12920.74%. This contributed to the annual value of $196.5 million for FY2024, which is 22973.53% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Revenue stood at $99.2 million for Q3 2025, which was up 12169.37% from $81.5 million recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Revenue registered a high of $99.2 million during Q3 2025, and its lowest value of $725000.0 during Q3 2022.
  • Its 4-year average for Revenue is $38.3 million, with a median of $30.9 million in 2024.
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Revenue skyrocketed by 403793.1% in 2023, and later soared by 3283.71% in 2025.
  • Over the past 4 years, Arcutis Biotherapeutics' Revenue (Quarter) stood at $3.0 million in 2022, then skyrocketed by 356.81% to $13.5 million in 2023, then surged by 427.58% to $71.4 million in 2024, then skyrocketed by 39.04% to $99.2 million in 2025.
  • Its Revenue was $99.2 million in Q3 2025, compared to $81.5 million in Q2 2025 and $65.8 million in Q1 2025.